Advanced search×

Data for Physiologically Based Pharmacokinetic Modeling in Neonatal Animals: Physiological Parameters in Mice and Sprague-Dawley Rats

Journal of Children's Health 2(3):363 - 411 (2004)

DOI: 10.1080/15417060490970430
Version: za2963e q8za1 q8zbd q8zcc q8zd1 q8zed q8zf9 q8zge

Similar articles you may find interesting…

  1. RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?

    Alzheimer Dis Assoc Disord 14(4):216-27 (2000) PMID 11186600

    Red blood cell (RBC) acetylcholinesterase (AChE) inhibition has been used as a peripheral surrogate marker for the activity of centrally acting AChE inhibitors (AChEIs) in the treatment of Alzheimer disease. As a valid peripheral surrogate marker, RBC AChE inhibition should reflect the central pharm...
  2. Acetylcholinesterase resynthesis after DFP poisoning; histochemical and biochemical study.

    Acta Histochem 62(2):293-301 (1978) PMID 83776

    DFP (0.4 to 2.0 mg/kg) was injected into the rat spinal ganglion leads to N. ischiadicus model system and examinations were made of the AChE inhibitory affect and the influence on the transport and resynthesis of the enzyme. It was concluded that the intraganglionically administered DFP inhibits the...
  3. Interaction of cycloheximide and diisopropylphosphorofluoridate (DFP) during subchronic administration in rat.

    Toxicol Appl Pharmacol 90(1):52-9 (1987) PMID 3629591

    Male Sprague-Dawley rats daily treated with DFP (0.5 mg/kg/day, sc) exhibited signs of cholinergic toxicity such as tremors and muscle fasciculations between Days 3 and 5 comparable to those observed 15 min after a single acute signs-producing dose (1.5 mg/kg, sc). Further administration of DFP (0.5...